Illumina appoints Joydeep Goswami as Interim CFO
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Auld is a seasoned Financial Executive with over 30 years of relevant experience
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The commercial production in the SML was started in November 1989.
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
Subscribe To Our Newsletter & Stay Updated